Michael Stephens

Michael Stephens practices at Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham.

Michael Stephens' NPI, 1508327396, was assigned on March 26, 2019. Michael Stephens graduated from Perelman School of Med at the University of Pennsylvania in 2019. Michael Stephens holds Massachusetts license 1014076.

Michael Stephens' primary practice is Massachusetts General Hospital, at 55 Fruit Street, Boston, MA 02114 in Suffolk County. The practice phone is (617) 726-2000.

Michael Stephens' primary practice is Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham. Michael Stephens is also affiliated with Brigham and Women's Hospital. The medical group on file is Massachusetts General Physicians Organization (MGPO). Dmand AI also links Michael Stephens to 1 more hospital, 1 community health center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Stephens practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Michael Stephens' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Michael Stephens is licensed in Massachusetts.

CMS data shows 1,605 Medicare services from Michael Stephens across 15 procedure codes in 2024, for 586 Medicare patients. Medicare paid $84,702 for them.

CMS counts 586 Medicare patients who saw Michael Stephens in 2024. The largest group is 65 to 74, with 250 patients. 70% of them have high blood pressure, and 70% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michael Stephens' median patient age at 62, with 48% women.

In 2024, Michael Stephens wrote 699 Medicare Part D claims for 257 patients. 76% of them were for generic drugs. CMS names the drug for 521 of them, across 17 drugs with 11 or more claims each, at $342,882 in total drug cost. In 2023, CMS named 234 claims across 11 drugs.

Michael Stephens accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Michael Stephens as offering telehealth. CMS counts 560 procedures of removal of skin lesions by Michael Stephens, more than 87% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 1 general payment to Michael Stephens from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $33.

Michael Stephens graduated from Perelman School of Med at the University of Pennsylvania in 2019.